Bioengineered Arteriovenous Grafts
The recent transition to clinical use of both allogeneic and autologous tissue-engineered vascular grafts represents a significant evolution in hemodialysis access.
By Todd N. McAllister, PhD; Sergio Garrido, MD; Jaime Velez, MD; Nicolas Chronos, MD; and Nicolas L'Heureux, PhD
